Britain's AstraZeneca launches $1 billion China investment fund with CICC

[ad_1]
AstraZeneca said it is lauching a new fund with China International Capital Corporation (CICC) to invest $1 billion (£777.00 million) in China’s healthcare sector, as it expands its research work in the country.

[ad_2]
Source link